Excessive prolongation of the bleeding time by aspirin in essential thrombocythemia is related to a decrease of large von Willebrand factor multimers in plasma

Annals of Hematology

Volumn 75, Issue 5-6, 1997, Pages 215-220

  Van Genderen, P J J ^a   Van Vliet, H H D M ^a   Prins, F J ^a   Van De Moesdijk, D ^a   Van Strik, R ^b   Zijlstra, F J ^b   Budde, U ^c   Michiels, J J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c AK Harburg   (Germany)

Author keywords

Aspirin; Bleeding; Bleeding time platelets; Essential thrombocythemia; von Willebrand factor

Indexed keywords

ACETYLSALICYLIC ACID; DESMOPRESSIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLEEDING; BLEEDING TIME; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTHEMIA;

ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; BLEEDING TIME; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; THROMBOCYTOSIS; VON WILLEBRAND FACTOR;

EID: 0030809909     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050345     Document Type: Article

References (17)

1. Barbui T, Buell M, Cortelazzo S, Viero P, De Gaetano G (1987) Aspirin and the risk of bleeding in patients with thrombocythemia. Am J Med 83:265-268
2. Bellucci S, Janvier M, Tobelem G, Flandrin G, Charpak Y, Berger R, Boiron M (1986) Essential thrombocythemias: clinical, evolutionary and biological data. Cancer 58:2440-2447
3. Budde U, Schaefer G, Mueller N, Egli H, Dent J, Ruggeri Z, Zimmerman T (1984) Acquired von Willebrand's disease in the myeloproliferative syndrome. Blood 64:981-985
4. Budde U, Scharf R, Franke P, Hartmann-Budde K, Dent J, Ruggeri Z (1993) Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma. Blood 82:1749-1757
5. Castaman G, Lattuada A, Ruggeri M, Tosetto A, Mannucci P, Rodeghiero F (1995) Platelet von Willebrand factor abnormalities in myeloproliferative syndromes. Am J Hematol 49:289-293
6. Castillo R, Monteagudo J, Escolar G, Ordinas A, Magallon M, Villar J (1993) Hemostatic effect of normal platelet transfusion in severe von Willebrand disease patients. Blood 77:1901-1905
7. Favaloro E, Facey D, Grispo L (1995) Laboratory assessment of von Willebrand factor: use of different assays can influence the diagnosis of von Willebrand's disease, dependent on differing sensitivity to sample preparation and differential recognition of high molecular weight vWF forms. Am J Clin Pathol 104:264-271
8. Fenaux P, Simon M, Caulier M, Lai J, Goudemand J, Bauters F (1990) Clinical course of essential thrombocythemia in 147 cases. Cancer 66:549-556
9. Lethagen S (1994) Desmopressin (DDAVP) and hemostasis. Ann Hematol 69:173-180
10. Leupin L, Beck E, Furian M, Bucher U (1983) Hämostasestörung mit verminderter Aktivität des von Willebrand faktors bei myeloproliferativen Syndromen. Schweiz Med Wochenschr 113:713-716
11. Stuart M, Miller M, Davey F, Wolk J (1979) The post-aspirin bleeding time: a screening test for evaluating haemostatic disorders. Br J Haematol 43:649-659
12. Tartaglia A, Goldberg J, Berk P, Wasserman L (1986) Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera. Semin Hematol 23:172-176
13. Van Genderen P, Michiels J (1993) Primary thrombocythemia: diagnosis, clinical manifestations and management. Ann Hematol 67:57-62
14. Van Genderen P, Michiels J, van der Poel - van de Luytgaarde S, van Vliet H (1994) Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: relationship with platelet count. Ann Hematol 69:81-84
15. Van Genderen P, Vink T, Michiels J, van't Veer M, Sixma J, van Vliet H (1994) Acquired von Willebrand disease caused by an autoantibody selectively inhibiting the binding of von Willebrand factor to collagen. Blood 84:3378-3384
16. Van Genderen P, Budde U, Michiels J, van Strik R, van Vliet H (1996) The reduction of large von Willebrand factor multimers in plasma in essential thrombocythemia is related to the platelet count. Br J Haematol 93:962-965
17. Van Genderen P, Mulder P, Waleboer M, van de Moesdijk D, Michiels J (1997) Prevention and treatment of thrombotic complications in essential thrombocythemia: efficacy and safety of aspirin. Br J Haematol 97:179-184